Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.
| Brand name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Generic name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Active ingredient(s) | HYDROCHLOROTHIAZIDE, LISINOPRIL |
| Distributed by / for | Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 |
| NDC | 68180-519-02 |
| Full product label | Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg, 500-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA, NDC 68180-519-02 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Nationwide within the United States |
| Quantity | 11,832 bottles |
| Recall initiated | 2019-07-19 |
| Report date | 2019-07-31 |
| Recall completed | 2020-09-09 |
| Recall number | D-1581-2019 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗